Agate Pass Investment Management LLC Boosts Stock Position in UnitedHealth Group Incorporated $UNH

Key Points

• Agate Pass Investment Management LLC increased its stake in UnitedHealth Group by 63.2%, holding a total of 2,758 shares valued at approximately $861,000.
• Bank of America raised its target price for UnitedHealth Group shares from $350.00 to $390.00, reflecting a positive sentiment, while analysts retain a majority "Buy" rating.
• The company reported a net margin of 5.04% with a revenue of $111.62 billion, slightly below analysts' expectations, and plans for a $2.21 quarterly dividend were executed recently.

Agate Pass Investment Management LLC lifted its position in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 63.2% in the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 2,758 shares of the healthcare conglomerate's stock after purchasing an additional 1,068 shares during the period. Agate Pass Investment Management LLC's holdings in UnitedHealth Group were worth $861,000 as of its most recent SEC filing.

Other institutional investors also recently modified their holdings of the company. Brighton Jones LLC raised its stake in UnitedHealth Group by 176.2% in the fourth quarter. Brighton Jones LLC now owns 44,249 shares of the healthcare conglomerate's stock worth $22,384,000 after buying an additional 28,231 shares in the last quarter. Revolve Wealth Partners LLC raised its stake in UnitedHealth Group by 137.1% in the fourth quarter. Revolve Wealth Partners LLC now owns 4,019 shares of the healthcare conglomerate's stock worth $2,033,000 after buying an additional 2,324 shares in the last quarter. GAMMA Investing LLC raised its stake in UnitedHealth Group by 7.4% in the first quarter. GAMMA Investing LLC now owns 15,838 shares of the healthcare conglomerate's stock worth $8,295,000 after buying an additional 1,089 shares in the last quarter. Ballew Advisors Inc bought a new position in UnitedHealth Group in the first quarter worth about $266,000. Finally, Rockland Trust Co. raised its stake in UnitedHealth Group by 1.5% in the first quarter. Rockland Trust Co. now owns 80,631 shares of the healthcare conglomerate's stock worth $42,230,000 after buying an additional 1,189 shares in the last quarter. 87.86% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

A number of brokerages have weighed in on UNH. Bank of America raised their target price on shares of UnitedHealth Group from $350.00 to $390.00 and gave the company a "neutral" rating in a research note on Wednesday. UBS Group reaffirmed a "buy" rating on shares of UnitedHealth Group in a research note on Thursday, July 17th. Cantor Fitzgerald reaffirmed an "overweight" rating and set a $440.00 target price on shares of UnitedHealth Group in a research note on Tuesday, August 26th. Robert W. Baird reaffirmed an "underperform" rating and set a $198.00 target price (down previously from $312.00) on shares of UnitedHealth Group in a research note on Thursday, July 31st. Finally, Mizuho raised their target price on shares of UnitedHealth Group from $300.00 to $430.00 and gave the company an "outperform" rating in a research note on Thursday. Sixteen research analysts have rated the stock with a Buy rating, seven have issued a Hold rating and four have given a Sell rating to the company's stock. According to MarketBeat.com, UnitedHealth Group presently has an average rating of "Hold" and an average price target of $383.09.

UnitedHealth Group Trading Down 3.6%

Shares of UNH stock opened at $354.30 on Friday. UnitedHealth Group Incorporated has a 12-month low of $234.60 and a 12-month high of $630.73. The company has a current ratio of 0.85, a quick ratio of 0.85 and a debt-to-equity ratio of 0.73. The firm's 50 day moving average is $318.21 and its 200 day moving average is $350.41. The stock has a market capitalization of $320.88 billion, a P/E ratio of 15.35, a P/E/G ratio of 2.38 and a beta of 0.47.

UnitedHealth Group (NYSE:UNH - Get Free Report) last issued its earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share (EPS) for the quarter, missing the consensus estimate of $4.45 by ($0.37). UnitedHealth Group had a return on equity of 23.32% and a net margin of 5.04%.The company had revenue of $111.62 billion during the quarter, compared to analysts' expectations of $111.75 billion. During the same quarter in the prior year, the business posted $6.80 EPS. The company's revenue for the quarter was up 12.9% compared to the same quarter last year. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. Research analysts expect that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Tuesday, September 23rd. Stockholders of record on Monday, September 15th were paid a dividend of $2.21 per share. This represents a $8.84 annualized dividend and a dividend yield of 2.5%. The ex-dividend date was Monday, September 15th. UnitedHealth Group's dividend payout ratio (DPR) is currently 38.30%.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.